← Back to Clinical Trials
Recruiting NCT06918535

NCT06918535 Progressive Muscle Relaxation Vs Muscle Energy Technique on Nonspecific Neck Pain in Prolonged Computer Users.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06918535
Status Recruiting
Phase
Sponsor IQRA University
Condition Neck Pain
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-04-22
Primary Completion 2026-04-15

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Progressive Muscle Relaxation TechniqueMuscle Energy Technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-04-22 with a primary completion date of 2026-04-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this randomized controlled trial is to assess the potential effectiveness of Progressive muscle relaxation technique (PMRT) vs Muscle energy technique (MET) as an intervention for releasing trigger points in SCM and upper trapezius in prolonged computer users. The study will be conducted in a workplace setting, where desk-type computer users are expected to regularly engage in their professional activities for ≥ 6 hours throughout the day, intermittently. This study will be conducted at the Outpatient Physiotherapy department of Sindh Institute of Physical Medicine and Rehabilitation, Karachi among 60 patients with nonspecific chronic neck pain on the basis of non-probability purposive sample technique. After taking informed consent, all participants will be randomly allocated into two groups through a investigator (blinded) the same investigator will be screening the individuals, doing baseline assessment, and post treatment assessment while another investigator will be providing intervention. Group 1 will receive Progressive muscle relaxation technique while Group 2 will receive Muscle Energy Technique on sternocleidomastoid and upper trapezius bilaterally. Patients will also be blinded. A total of 12 sessions will be provided. Outcomes will be assessed at baseline and post treatment after 2 weeks intervention.

Eligibility Criteria

Inclusion Criteria: * Persons using computer more than 6 hours throughout the day, intermittently both genders. * Age between 20-45. * Hypertonicity of trapezius muscle and SCM muscle. Specifically, those workers have neck pain and stiffness (including trouble tilting or turning head). Patients who reported small tightening and spasm at the posterior aspect of their neck are included, also associated with more diffuse neck pain patterns that included the following: headache, (upper back, neck and shoulder pain) numbness/ tingling in the hand/arm. * Pain intensity of 2 on the NRS and presence of at least one latent trigger point in a taut band in the neck region. Exclusion Criteria: * Recent trauma to the cervical region * Exclusion criteria based on with any serious pathology such as specific neck pain due to disc prolapsed, tumor of cervical spine, whiplash injury, cervical fractures, Cervicogenic headache, and any neurological signs consistent with nerve root compression

Contact & Investigator

Central Contact

Syeda Waniya Riaz, PhD (scholar), MSAPT, DPT

✉ waniya.riaz@iqra.edu.pk

📞 +923352783584

Principal Investigator

Syeda Waniya Riaz, PhD (scholar), MSAPT, DPT

PRINCIPAL INVESTIGATOR

IQRA University

Frequently Asked Questions

Who can join the NCT06918535 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06918535 currently recruiting?

Yes, NCT06918535 is actively recruiting participants. Contact the research team at waniya.riaz@iqra.edu.pk for enrollment information.

Where is the NCT06918535 trial being conducted?

This trial is being conducted at Karachi, Pakistan.

Who is sponsoring the NCT06918535 clinical trial?

NCT06918535 is sponsored by IQRA University. The principal investigator is Syeda Waniya Riaz, PhD (scholar), MSAPT, DPT at IQRA University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology